FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054893182> ?p ?o ?g. }

• W2054893182 endingPage "S172" @default.
• W2054893182 startingPage "S172" @default.
• W2054893182 abstract "After exposure to ionizing radiation, eukaryotic cells undergo a G2 delay which contributes to the ability of cells to survive irradiation. For some radioresistant cell lines, this delay is prolonged. Entry of cells into mitosis is regulated by a complex of two proteins cyclin B, and the serine-threonine p34cdc2 kinase. When this complex is activated, it undergoes a transport from cytoplasm into the nucleus and phosphorylates proteins which lead to mitosis. P34cdc2 kinase is activated by binding to cyclin B and by phosphorylation/dephosphorylation of p34cdc2. Since G2 delay after irradiation has been correlated with a rapid inhibition of p34cdc2 activity and an enhanced tyrosine phosphorylation, we hypothesized that radioresistant tumors could have a lack in regulation of p34cdc2 kinase activity. In this study, we entered 32 patients treated, from 1983 through 1989 at the Claudius Regaud Center, for head and neck squamous cell carcinoma by surgery and standard post-operative doses of radiotherapy. The paraffin embedded tumor specimens had been sampled before radiotherapy for long term controlled patients (n = 7) and before and after radiotherapy for patients who had developed a recurrence in the irradiation fields (n = 25). Immunohistochemical staining was performed with monoclonal antibodies against p34cdc2 (sc-54) and cyclin B (sc-245). A semi-quantitative score was used. For p34cdc2 analysis, no difference in intensity of staining was observed between long term controlled patients and those who recurred or, when there was a recurrence before and after radiotherapy. However, there was a highly significant difference (P < 0.001) in p34cdc2 cell localization with a preferential cytoplasmic localization only for the patients who have a recurrence in the radiotherapy fields. This cytoplasmic localization was present in the primary tumor before radiotherapy and in the recurrence, too. No preferential localization was observed in long term controlled patients. For cyclin B, no difference in intensity of staining was observed anywhere and conversely to p34cdc2, no difference in localization appeared in long term controlled patients nor for patients who have had a recurrence. No correlation existed between localization of p34cdc2 and those of cyelin B in patients who recurred. Our results suggest a probably intrinsic abnormality of p34cdc2 activity and a lack of association between eyelin B and p34cdc2 in head and neck radioresistant squamous cell carcinoma. After exposure to ionizing radiation, eukaryotic cells undergo a G2 delay which contributes to the ability of cells to survive irradiation. For some radioresistant cell lines, this delay is prolonged. Entry of cells into mitosis is regulated by a complex of two proteins cyclin B, and the serine-threonine p34cdc2 kinase. When this complex is activated, it undergoes a transport from cytoplasm into the nucleus and phosphorylates proteins which lead to mitosis. P34cdc2 kinase is activated by binding to cyclin B and by phosphorylation/dephosphorylation of p34cdc2. Since G2 delay after irradiation has been correlated with a rapid inhibition of p34cdc2 activity and an enhanced tyrosine phosphorylation, we hypothesized that radioresistant tumors could have a lack in regulation of p34cdc2 kinase activity. In this study, we entered 32 patients treated, from 1983 through 1989 at the Claudius Regaud Center, for head and neck squamous cell carcinoma by surgery and standard post-operative doses of radiotherapy. The paraffin embedded tumor specimens had been sampled before radiotherapy for long term controlled patients (n = 7) and before and after radiotherapy for patients who had developed a recurrence in the irradiation fields (n = 25). Immunohistochemical staining was performed with monoclonal antibodies against p34cdc2 (sc-54) and cyclin B (sc-245). A semi-quantitative score was used. For p34cdc2 analysis, no difference in intensity of staining was observed between long term controlled patients and those who recurred or, when there was a recurrence before and after radiotherapy. However, there was a highly significant difference (P < 0.001) in p34cdc2 cell localization with a preferential cytoplasmic localization only for the patients who have a recurrence in the radiotherapy fields. This cytoplasmic localization was present in the primary tumor before radiotherapy and in the recurrence, too. No preferential localization was observed in long term controlled patients. For cyclin B, no difference in intensity of staining was observed anywhere and conversely to p34cdc2, no difference in localization appeared in long term controlled patients nor for patients who have had a recurrence. No correlation existed between localization of p34cdc2 and those of cyelin B in patients who recurred. Our results suggest a probably intrinsic abnormality of p34cdc2 activity and a lack of association between eyelin B and p34cdc2 in head and neck radioresistant squamous cell carcinoma." @default.
• W2054893182 created "2016-06-24" @default.
• W2054893182 creator A5008647126 @default.
• W2054893182 creator A5018267264 @default.
• W2054893182 creator A5046580775 @default.
• W2054893182 creator A5083669252 @default.
• W2054893182 creator A5089647583 @default.
• W2054893182 creator A5091018870 @default.
• W2054893182 date "1995-11-01" @default.
• W2054893182 modified "2023-09-23" @default.
• W2054893182 title "820 Immunohistochemical analysis of p34cdc2 and cyclin B cell localization in recurrent head and neck squamous cell carcinoma after irradiation" @default.
• W2054893182 doi "https://doi.org/10.1016/0959-8049(95)96069-p" @default.
• W2054893182 hasPublicationYear "1995" @default.
• W2054893182 type Work @default.
• W2054893182 sameAs 2054893182 @default.
• W2054893182 citedByCount "0" @default.
• W2054893182 crossrefType "journal-article" @default.
• W2054893182 hasAuthorship W2054893182A5008647126 @default.
• W2054893182 hasAuthorship W2054893182A5018267264 @default.
• W2054893182 hasAuthorship W2054893182A5046580775 @default.
• W2054893182 hasAuthorship W2054893182A5083669252 @default.
• W2054893182 hasAuthorship W2054893182A5089647583 @default.
• W2054893182 hasAuthorship W2054893182A5091018870 @default.
• W2054893182 hasConcept C11960822 @default.
• W2054893182 hasConcept C120089663 @default.
• W2054893182 hasConcept C120504264 @default.
• W2054893182 hasConcept C126322002 @default.
• W2054893182 hasConcept C1491633281 @default.
• W2054893182 hasConcept C153911025 @default.
• W2054893182 hasConcept C203014093 @default.
• W2054893182 hasConcept C204232928 @default.
• W2054893182 hasConcept C2776530083 @default.
• W2054893182 hasConcept C2776833033 @default.
• W2054893182 hasConcept C2778437423 @default.
• W2054893182 hasConcept C29537977 @default.
• W2054893182 hasConcept C502942594 @default.
• W2054893182 hasConcept C509974204 @default.
• W2054893182 hasConcept C55493867 @default.
• W2054893182 hasConcept C58962609 @default.
• W2054893182 hasConcept C71924100 @default.
• W2054893182 hasConcept C86803240 @default.
• W2054893182 hasConcept C93304396 @default.
• W2054893182 hasConcept C95444343 @default.
• W2054893182 hasConcept C9743823 @default.
• W2054893182 hasConceptScore W2054893182C11960822 @default.
• W2054893182 hasConceptScore W2054893182C120089663 @default.
• W2054893182 hasConceptScore W2054893182C120504264 @default.
• W2054893182 hasConceptScore W2054893182C126322002 @default.
• W2054893182 hasConceptScore W2054893182C1491633281 @default.
• W2054893182 hasConceptScore W2054893182C153911025 @default.
• W2054893182 hasConceptScore W2054893182C203014093 @default.
• W2054893182 hasConceptScore W2054893182C204232928 @default.
• W2054893182 hasConceptScore W2054893182C2776530083 @default.
• W2054893182 hasConceptScore W2054893182C2776833033 @default.
• W2054893182 hasConceptScore W2054893182C2778437423 @default.
• W2054893182 hasConceptScore W2054893182C29537977 @default.
• W2054893182 hasConceptScore W2054893182C502942594 @default.
• W2054893182 hasConceptScore W2054893182C509974204 @default.
• W2054893182 hasConceptScore W2054893182C55493867 @default.
• W2054893182 hasConceptScore W2054893182C58962609 @default.
• W2054893182 hasConceptScore W2054893182C71924100 @default.
• W2054893182 hasConceptScore W2054893182C86803240 @default.
• W2054893182 hasConceptScore W2054893182C93304396 @default.
• W2054893182 hasConceptScore W2054893182C95444343 @default.
• W2054893182 hasConceptScore W2054893182C9743823 @default.
• W2054893182 hasLocation W20548931821 @default.
• W2054893182 hasOpenAccess W2054893182 @default.
• W2054893182 hasPrimaryLocation W20548931821 @default.
• W2054893182 hasRelatedWork W2047197979 @default.
• W2054893182 hasRelatedWork W2048990794 @default.
• W2054893182 hasRelatedWork W2084554663 @default.
• W2054893182 hasRelatedWork W2097194453 @default.
• W2054893182 hasRelatedWork W2118197190 @default.
• W2054893182 hasRelatedWork W2135088051 @default.
• W2054893182 hasRelatedWork W2144942522 @default.
• W2054893182 hasRelatedWork W2160625820 @default.
• W2054893182 hasRelatedWork W2342369214 @default.
• W2054893182 hasRelatedWork W4297261219 @default.
• W2054893182 hasVolume "31" @default.
• W2054893182 isParatext "false" @default.
• W2054893182 isRetracted "false" @default.
• W2054893182 magId "2054893182" @default.
• W2054893182 workType "article" @default.